Putting our patients at the heart of everything we do
International Clinical Trials Day at King's
14 June 2018 - Events were held across the Trust to mark International Clinical Trials Day
Researchers, clinicians and health and social care staff celebrated clinical research at King’s for this year’s International Clinical Trials Day.
The annual awareness day on 20 May marks the work of James Lind who held the first clinical trial in 1747 on board the HMS Salisbury when he experimented with different remedies for helping 12 men with scurvy. The Scottish Physician found that sailors given citrus fruits made an impressive recovery compared to the other treatments.
There was a randomised clinical trial involving jelly beans to celebrate International Clinical Trials Day at King's College Hospital this year and researchers from across the Trust demonstrated how they’re developing the treatments of the future through research.
The Princess Royal University Hospital (PRUH) had several stalls where members of the public could find out more about current research studies in different specialties.
Ann-Marie Murtagh, Director of R&D operations at King’s, said "International Clinical Trials Day across King’s was a huge success - with many research stalls that had been very thoughtfully put together. It was an extremely well attended day, a great opportunity for networking amongst research teams and trust staff and also for real patient and public engagement."
Every year, more than half a million people help the NHS to improve healthcare and develop life-saving treatments by taking part in research.
This year the NHS is turning 70, which is a good opportunity to celebrate the important role that research plays within the health service. Research in the NHS has consistently improved treatments for patients over the last 70 years having a positive impact on many people’s lives.
We have placed cookies on your computer to help make this website better. You can change your cookie settings at any time. Otherwise, we'll assume you're OK to continue.